Citadel Advisors »

Processa Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Processa Pharmaceuticals (PCSA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Processa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Processa Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Processa Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $41k 21k 1.92

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Processa Pharmaceuticals

Connective Capital Management
Stonepine Capital Management
Geode Capital Management
Citadel Advisors
XTX Topco
Jane Street
Vanguard Capital Management
Intl Fcstone
Vanguard Fiduciary Trust
UBS Group
Tower Research Capital
Citigroup
Jones Financial Companies, L.L

View all funds holding Processa Pharmaceuticals